ZymoGenetics, Inc. · Seattle, WA United States
Key ZymoGenetics, Inc. Financials
| Company Type | Subsidiary - Single Location |
|---|---|
| Fiscal Year-End | December |
| 2001 Sales (mil.) | $17.8 |
| 2009 Employees | 323 |
ZymoGenetics, Inc. Income Statement
| Dec 01 | Dec 00 | Dec 98 | |
| Revenue | 17.8 | 32.5 | 66.7 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | 17.8 | 32.5 | 66.7 |
| Gross Profit Margin | -- | -- | -- |
| SG&A Expense | 14.0 | 12.1 | 9.3 |
| Depreciation & Amortization | 6.2 | 5.7 | -- |
| Operating Income | (44.2) | (28.9) | 7.5 |
| Operating Margin | -248% | -89.1% | 11.3% |
| Nonoperating Income | 0.1 | (0.1) | 0.0 |
| Nonoperating Expenses | -- | -- | 0.6 |
| Income Before Taxes | (37.0) | (24.5) | 7.0 |
| Income Taxes | (0.1) | 5.9 | 1.3 |
| Net Income After Taxes | (36.9) | (30.4) | 5.7 |
| Continuing Operations | (36.9) | (30.4) | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (36.9) | (30.4) | -- |
| Total Net Income | (36.9) | (30.4) | 5.7 |
| Net Profit Margin | -206.9% | -93.6% | 8.6% |
| Diluted EPS from Total Net Income | (4.85) | (3.38) | -- |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
ZymoGenetics, Inc. Balance Sheet
| Assets | Dec 01 | Dec 00 | Dec 98 |
| Current Assets | |||
| Cash | 36.4 | 173.0 | -- |
| Net Receivables | 4.1 | 4.4 | -- |
| Inventories | -- | -- | -- |
| Other Current Assets | 113.0 | 1.7 | -- |
| Total Current Assets | 153.4 | 179.1 | -- |
| Net Fixed Assets | 49.1 | 46.4 | -- |
| Other Noncurrent Assets | 2.9 | 3.1 | -- |
| Total Assets | 205.4 | 228.6 | -- |
| Liabilities | Dec 01 | Dec 00 | Dec 98 |
| Current Liabilities | |||
| Accounts Payable | 4.1 | 2.0 | -- |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 10.8 | 10.9 | -- |
| Total Current Liabilities | 14.9 | 12.8 | -- |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 269.9 | 243.1 | -- |
| Total Liabilities | 284.8 | 255.9 | -- |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | (79.4) | (27.3) | -- |
| Total Equity | (79.4) | (27.3) | -- |
| Shares Outstanding (thou.) | 85,904.5 | 85,904.5 | -- |
All amounts in millions of US Dollars except per share amounts.
ZymoGenetics, Inc. Cash Flow Statement
| Dec 01 | Dec 00 | Dec 98 | |
| Net Operating Cash Flow | (19) | (38) | -- |
| Net Investing Cash Flow | (117.7) | (5.6) | -- |
| Net Financing Cash Flow | 0.0 | 196.9 | |
| Net Change in Cash | (136.6) | 153.3 | |
| Depreciation & Amortization | 6.2 | 5.7 | |
| Capital Expenditures | (8.2) | (5.6) | |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.